Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-08-08 Purchase |
2024-08-09 5:52 pm |
LIGAND PHARMACEUTICALS INC | LGND | Davis Todd C Chief Executive Officer |
2,500 | $97.39 | $243,481 | 123,010 (Direct) |
View |
| 2023-09-22 Purchase |
2023-09-25 4:44 pm |
LIGAND PHARMACEUTICALS INC | LGND | Davis Todd C CHIEF EXECUTIVE OFFICER |
4,000 | $59.38 | $237,529 | 73,090 (Direct) |
View |
| 2021-02-10 Sale |
2021-02-12 6:23 pm |
LIGAND PHARMACEUTICALS INC | LGND | Davis Todd C Director |
5,083 | $213.14 | $1,083,410 | 50,152 (Direct) |
View |
| 2020-08-18 Sale |
2020-08-20 4:16 pm |
BIODELIVERY SCIENCES INTERNATIONAL INC | BDSI | Davis Todd C Director |
50,000 | $4.99 | $249,500 | 217,914 (Direct) |
View |
| 2020-04-28 Sale |
2020-04-30 4:10 pm |
Vaxart Inc. | VXRT | Davis Todd C Director |
60,000 | $3.275 | $196,500 | 120,000 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-03-04 Option Award |
2025-03-06 6:54 pm |
N/A 2035-03-04 |
LIGAND PHARMACEUTICALS INC | LGND | Davis Todd C Chief Executive Officer |
114,858 | $0 | 245,200 (Direct) |
View |
| 2025-02-14 Tax Withholding |
2025-02-19 8:44 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Davis Todd C Chief Executive Officer |
13,452 | $120 | 130,342 (Direct) |
View |
| 2025-02-14 Option Award |
2025-02-19 8:44 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Davis Todd C Chief Executive Officer |
20,784 | $0 | 130,342 (Direct) |
View |
| 2024-12-13 Option Award |
2024-12-17 8:44 pm |
N/A 2034-12-13 |
PALVELLA THERAPEUTICS INC. | PVLA | Davis Todd C Director |
24,700 | $0 | 24,700 (Direct) |
View |
Ownership |
2024-12-16 7:41 pm |
N/A N/A |
PALVELLA THERAPEUTICS INC. | PVLA | Davis Todd C Director |
0 | $0 | 128,651 (Direct) |
View |
| 2024-11-13 Option Award |
2024-11-15 4:22 pm |
N/A 2024-11-13 |
Chromocell Therapeutics Corp | CHRO | Davis Todd C Director |
49,605 | $0 | 263,306 (Direct) |
View |
| 2024-06-28 Other |
2024-07-02 7:44 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Davis Todd C Chief Executive Officer |
350 | $60.71 | 120,860 (Direct) |
View |
| 2024-06-14 Option Award |
2024-06-18 8:00 pm |
N/A 2034-06-14 |
Chromocell Therapeutics Corp | CHRO | Davis Todd C Director |
128,977 | $0 | 213,701 (Direct) |
View |
| 2024-03-25 Exercise |
2024-03-27 5:47 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Davis Todd C Chief Executive Officer |
2,156 | $68.51 | 120,160 (Direct) |
View |
| 2024-03-25 Exercise |
2024-03-27 5:47 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Davis Todd C Chief Executive Officer |
2,855 | $67.24 | 120,160 (Direct) |
View |
| 2024-03-25 Exercise |
2024-03-27 5:47 pm |
N/A 2032-06-10 |
LIGAND PHARMACEUTICALS INC | LGND | Davis Todd C Chief Executive Officer |
16,015 | $0 | 120,160 (Direct) |
View |
| 2024-03-25 Exercise |
2024-03-27 5:47 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Davis Todd C Chief Executive Officer |
7,448 | $46.2 | 120,160 (Direct) |
View |
| 2024-03-25 Exercise |
2024-03-27 5:47 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Davis Todd C Chief Executive Officer |
3,556 | $66.19 | 120,160 (Direct) |
View |
| 2024-02-27 Option Award |
2024-02-29 6:49 pm |
N/A 2034-02-27 |
LIGAND PHARMACEUTICALS INC | LGND | Davis Todd C CHIEF EXECUTIVE OFFICER |
164,159 | $0 | 235,868 (Direct) |
View |
| 2024-02-21 Conversion |
2024-02-23 5:15 pm |
2024-02-21 2024-02-29 |
Chromocell Therapeutics Corp | CHRO | Davis Todd C Director |
175,000 | $0 | 29,167 (Direct) |
View |
| 2024-02-21 Exercise |
2024-02-23 5:15 pm |
N/A N/A |
Chromocell Therapeutics Corp | CHRO | Davis Todd C Director |
29,167 | $4.8 | 29,167 (Direct) |
View |
| 2024-02-15 Tax Withholding |
2024-02-16 8:10 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Davis Todd C CHIEF EXECUTIVE OFFICER |
1,381 | $74.65 | 71,709 (Direct) |
View |
Ownership |
2024-02-15 8:02 pm |
N/A 2023-12-31 |
Chromocell Therapeutics Corp | CHRO | Davis Todd C Director |
0 | $0 | 230,557 (Direct) |
View |
| 2023-06-09 Tax Withholding |
2023-06-13 6:52 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Davis Todd C CHIEF EXECUTIVE OFFICER |
420 | $73.76 | 69,090 (Direct) |
View |
| 2023-02-23 Option Award |
2023-02-27 8:50 pm |
N/A 2033-02-23 |
LIGAND PHARMACEUTICALS INC | LGND | Davis Todd C Chief Executive Officer |
63,183 | $0 | 114,969 (Direct) |
View |
| 2022-12-22 Option Award |
2022-12-27 6:26 pm |
N/A 2032-12-22 |
LIGAND PHARMACEUTICALS INC | LGND | Davis Todd C Chief Executive Officer |
2,081 | $0 | 2,081 (Direct) |
View |
| 2022-12-05 Option Award |
2022-12-06 8:25 pm |
N/A 2032-12-05 |
LIGAND PHARMACEUTICALS INC | LGND | Davis Todd C Chief Executive Officer |
132,000 | $0 | 132,000 (Direct) |
View |
| 2022-08-04 Option Award |
2022-08-08 6:26 pm |
N/A 2032-08-03 |
Vaxart Inc. | VXRT | Davis Todd C Director |
51,599 | $0 | 170,129 (Direct) |
View |
| 2022-06-10 Option Award |
2022-06-13 6:46 pm |
N/A 2032-06-10 |
LIGAND PHARMACEUTICALS INC | LGND | Davis Todd C Director |
5,344 | $0 | 56,126 (Direct) |
View |
| 2022-03-22 Other |
2022-03-22 5:12 pm |
N/A N/A |
BIODELIVERY SCIENCES INTERNATIONAL INC | BDSI | Davis Todd C Director |
252,207 | $0 | 252,207 (Direct) |
View |
| 2022-01-27 Option Award |
2022-02-01 4:06 pm |
N/A 2023-01-27 |
BIODELIVERY SCIENCES INTERNATIONAL INC | BDSI | Davis Todd C Director |
15,369 | $0 | 361,021 (Direct) |
View |
| 2022-01-27 Exercise |
2022-02-01 4:06 pm |
N/A 2023-01-27 |
BIODELIVERY SCIENCES INTERNATIONAL INC | BDSI | Davis Todd C Director |
7,684 | $0 | 361,021 (Direct) |
View |
| 2022-01-27 Option Award |
2022-02-01 4:06 pm |
N/A 2032-01-26 |
BIODELIVERY SCIENCES INTERNATIONAL INC | BDSI | Davis Todd C Director |
85,760 | $3.66 | 361,021 (Direct) |
View |
| 2021-12-22 Gift |
2021-12-23 6:07 pm |
N/A N/A |
Vaxart Inc. | VXRT | Davis Todd C Director |
1,470 | $0 | 118,530 (Direct) |
View |
| 2021-08-06 Exercise |
2021-08-10 6:15 pm |
N/A 2022-08-01 |
BIODELIVERY SCIENCES INTERNATIONAL INC | BDSI | Davis Todd C Director |
30,000 | $0 | 259,523 (Direct) |
View |
| 2021-06-16 Option Award |
2021-06-17 7:25 pm |
N/A 2031-06-15 |
Vaxart Inc. | VXRT | Davis Todd C Director |
15,097 | $0 | 15,097 (Direct) |
View |
| 2021-06-04 Option Award |
2021-06-07 9:25 pm |
N/A 2031-06-04 |
LIGAND PHARMACEUTICALS INC | LGND | Davis Todd C Director |
3,899 | $0 | 54,051 (Direct) |
View |
| 2018-12-26 Ownership |
2021-02-16 4:02 pm |
N/A N/A |
BIODELIVERY SCIENCES INTERNATIONAL INC | BDSI | Davis Todd C Director |
3,391 | $0 | 214,523 (Direct) |
View |
| 2021-02-11 Exercise |
2021-02-12 6:23 pm |
N/A 2028-06-18 |
LIGAND PHARMACEUTICALS INC | LGND | Davis Todd C Director |
2,474 | $0 | 50,152 (Direct) |
View |
| 2021-02-11 Exercise |
2021-02-12 6:23 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Davis Todd C Director |
2,474 | $195.91 | 50,152 (Direct) |
View |
| 2021-01-27 Exercise |
2021-01-27 7:02 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Davis Todd C Director |
2,456 | $113.5 | 52,761 (Direct) |
View |
| 2021-01-27 Exercise |
2021-01-27 7:02 pm |
N/A 2027-05-25 |
LIGAND PHARMACEUTICALS INC | LGND | Davis Todd C Director |
2,456 | $0 | 52,761 (Direct) |
View |
| 2020-08-07 Exercise |
2020-08-11 4:50 pm |
N/A 2022-08-01 |
BIODELIVERY SCIENCES INTERNATIONAL INC | BDSI | Davis Todd C Director |
30,000 | $0 | 312,914 (Direct) |
View |
| 2020-06-10 Option Award |
2020-06-12 6:34 pm |
N/A 2030-06-10 |
LIGAND PHARMACEUTICALS INC | LGND | Davis Todd C Director |
3,299 | $0 | 52,773 (Direct) |
View |
| 2020-06-08 Option Award |
2020-06-09 4:42 pm |
2021-06-08 2030-06-07 |
Vaxart Inc. | VXRT | Davis Todd C Director |
65,700 | $0 | 65,700 (Direct) |
View |